These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6751023)

  • 1. Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs.
    Deckert T; Hansen B; Kølendorf K; Poulsen JS; Smith M
    Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):30-7. PubMed ID: 6751023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.
    Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R
    Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of subcutaneous NPH insulin in diabetics.
    Kølendorf K; Bojsen J
    Clin Pharmacol Ther; 1982 Apr; 31(4):494-500. PubMed ID: 7060331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotelemetric detection of the disappearance of subcutaneously injected 125I-NPH insulin.
    Kølendorf K; Bojsen J
    Clin Physiol; 1982 Feb; 2(1):13-20. PubMed ID: 7049511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients.
    Kølendorf K; Bojsen J; Deckert T
    Horm Metab Res; 1983 Jun; 15(6):274-8. PubMed ID: 6409773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 125I used for labelling of proteins in an absorption model changes the absorption rate of insulin aspart.
    Sohoel A; Plum A; Frokjaer S; Thygesen P
    Int J Pharm; 2007 Feb; 330(1-2):114-20. PubMed ID: 17070660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo).
    Kølendorf K; Aaby P; Westergaard S; Deckert T
    Eur J Clin Pharmacol; 1978 Nov; 14(2):117-24. PubMed ID: 363432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of circulating epinephrine on absorption of subcutaneously injected insulin.
    Fernqvist E; Gunnarsson R; Linde B
    Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in absorption of NPH insulin due to intramuscular injection.
    Vaag A; Handberg A; Lauritzen M; Henriksen JE; Pedersen KD; Beck-Nielsen H
    Diabetes Care; 1990 Jan; 13(1):74-6. PubMed ID: 2404719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically important differences in insulin absorption from abdomen in IDDM.
    Frid A; Linde B
    Diabetes Res Clin Pract; 1993; 21(2-3):137-41. PubMed ID: 8269814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and miscibility of regular porcine insulin after subcutaneous injection of insulin-treated diabetic patients.
    Kølendorf K; Bojsen J; Deckert T
    Diabetes Care; 1983; 6(1):6-9. PubMed ID: 6341016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of isophane (NPH) insulin and its clinical implications.
    Lauritzen T; Pramming S; Gale EA; Deckert T; Binder C
    Br Med J (Clin Res Ed); 1982 Jul; 285(6336):159-62. PubMed ID: 6807390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs.
    Jørgensen KH; Hansen AK; Buschard K
    Diabetes Res Clin Pract; 2000 Dec; 50(3):161-7. PubMed ID: 11106830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massage-enhanced insulin absorption--increased distribution or dissociation of insulin?
    Linde B; Philip A
    Diabetes Res; 1989 Aug; 11(4):191-4. PubMed ID: 2696618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat.
    Okumura K; Komada F; Hori R
    J Pharmacobiodyn; 1985 Jan; 8(1):25-32. PubMed ID: 3891962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):942-8. PubMed ID: 1797506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans.
    Hori R; Komada F; Iwakawa S; Seino Y; Okumura K
    Pharm Res; 1989 Sep; 6(9):813-6. PubMed ID: 2682592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J
    BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action profile of cobalt(III)-insulin. A novel principle of protraction of potential use for basal insulin delivery.
    Kurtzhals P; Ribel U
    Diabetes; 1995 Dec; 44(12):1381-5. PubMed ID: 7589842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.